Q1 2011

Filed Feb 14, 2011 · 10-Q · 45 days after period end · 0001062993-11-000585

Q1 2011 · 10-Q

Revenue—

Net Income

-$1.89M

no prior Q1 2010 on file

EPS Diluted

-$0.08

no prior Q1 2010 on file

Operating Income-$1,369,145—

Operating Cash Flow-$1,083,961—

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2010 · filed Feb 14, 2011 · 45 d after period end

Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR